The Emerging Role of microRNAs in Polyglutamine Diseases

被引：25

作者：

Dong, Xiaoyu ^{[1
]}

Cong, Shuyan ^{[1
]}

机构：

[1] China Med Univ, Dept Neurol, Shengjing Hosp, Shenyang, Liaoning, Peoples R China

来源：

FRONTIERS IN MOLECULAR NEUROSCIENCE | 2019年 / 12卷

基金：

中国国家自然科学基金;

关键词：

microRNAs; polyglutamine diseases; biomarker; neurodegeneration; therapy; HUNTINGTONS-DISEASE; CELLULAR-MODEL; GENE; ATAXIA; MUTANT; DYSREGULATION; SUPPRESSION; EXPRESSION; BIOMARKERS; NEUROGENESIS;

D O I：

10.3389/fnmol.2019.00156

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

MicroRNAs (miRNAs) are small non-coding molecules that regulate a large amount of post-transcriptional repressor genes by recognizing semi-complementary target sequences that are normally located in the 3' UTR of the mRNA. Altered expression of miRNA has been related to several pathological processes, including polyglutamine (Poly Q) diseases. Specific expression patterns in the circulating fluids and brain parenchyma have been speculated as potential biomarkers for Poly Q disease diagnosis and prognosis. Several miRNAs have been consistently identified in diseases including Huntington's disease (HD) and spinocerebellar ataxia (SCA). In our review, we describe the emerging role of miRNAs in Poly Q diseases and provide an overview on general miRNA biology, implications in pathophysiology, and their potential roles as future biomarkers and applications for therapy.

引用

页数：11

共 108 条

[1] Machado-Joseph Disease: from first descriptions to new perspectives [J].

Bettencourt, Conceicao ;

Lima, Manuela .

ORPHANET JOURNAL OF RARE DISEASES, 2011, 6

[2] MicroRNA-132,-134, and -138: a microRNA troika rules in neuronal dendrites [J].

Bicker, Silvia ;

Lackinger, Martin ;

Weiss, Kerstin ;

Schratt, Gerhard .

CELLULAR AND MOLECULAR LIFE SCIENCES, 2014, 71 (20) :3987-4005

[3]

Borel Florie, 2011, J RNAi Gene Silencing, V7, P434

[4] Wide Profiling of Circulating MicroRNAs in Spinocerebellar Ataxia Type 7 [J].

Borgonio-Cuadra, Veronica M. ;

Valdez-Vargas, Claudia ;

Romero-Cordoba, Sandra ;

Hidalgo-Miranda, Alfredo ;

Tapia-Guerrero, Yessica ;

Cerecedo-Zapata, Cesar M. ;

Hernandez-Hernandez, Oscar ;

Cisneros, Bulmaro ;

Magana, Jonathan J. .

MOLECULAR NEUROBIOLOGY, 2019, 56 (09) :6106-6120

[5] Nonallele-specific Silencing of Mutant and Wild-type Huntingtin Demonstrates Therapeutic Efficacy in Huntington's Disease Mice [J].

Boudreau, Ryan L. ;

McBride, Jodi L. ;

Martins, Ines ;

Shen, Shihao ;

Xing, Yi ;

Carter, Barrie J. ;

Davidson, Beverly L. .

MOLECULAR THERAPY, 2009, 17 (06) :1053-1063

[6] Unravelling Endogenous MicroRNA System Dysfunction as a New Pathophysiological Mechanism in Machado-Joseph Disease [J].

Carmona, Vitor ;

Cunha-Santos, Janete ;

Onofre, Isabel ;

Simoes, Ana Teresa ;

Vijayakumar, Udaya ;

Davidson, Beverly L. ;

de Almeida, Luis Pereira .

MOLECULAR THERAPY, 2017, 25 (04) :1038-1055

[7] Potent and Selective Antisense Oligonucleotides Targeting Single-Nucleotide Polymorphisms in the Huntington Disease Gene/Allele-Specific Silencing of Mutant Huntingtin [J].

Carroll, Jeffrey B. ;

Warby, Simon C. ;

Southwell, Amber L. ;

Doty, Crystal N. ;

Greenlee, Sarah ;

Skotte, Niels ;

Hung, Gene ;

Bennett, C. Frank ;

Freier, Susan M. ;

Hayden, Michael R. .

MOLECULAR THERAPY, 2011, 19 (12) :2178-2185

[8] Down-regulation of miR-9*in the peripheral leukocytes of Huntington's disease patients [J].

Chang, Kuo-Hsuan ;

Wu, Yih-Ru ;

Chen, Chiung-Mei .

ORPHANET JOURNAL OF RARE DISEASES, 2017, 12

[9] Developmental Insights Into the Pathology of and Therapeutic Strategies for DM1: Back to the Basics [J].

Chau, Anthony ;

Kalsotra, Auinash .

DEVELOPMENTAL DYNAMICS, 2015, 244 (03) :377-390

[10] The Role of MiR-132 in Regulating Neural Stem Cell Proliferation, Differentiation and Neuronal Maturation [J].

Chen, Dong ;

Hu, Siyuan ;

Wu, Zhong ;

Liu, Jie ;

Li, Shaohua .

CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2018, 47 (06) :2319-2330

← 1 2 3 4 5 6 7 8 9 10 →